Coulter Partners places new Chief Executive Officer at ArcticZymes London,

London, 10th August 2023 – Coulter Partners, the global experts in Executive Search and Leadership Development in Life Sciences, Health and Tech, is pleased to announce the placement of Michael Akoh, ArcticZymes’ new Chief Executive Officer.

ArcticZymes Technologies ASA (OSE:AZT) is a Norwegian life sciences company focused on the development, manufacturing and commercialization of novel recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing.

Commenting on his appointment at ArcticZymes Michael Akoh said: “I am delighted to have been appointed to lead ArcticZymes. It is a business with a global presence, a talented team and a strong reputation as an innovative supplier of novel enzymes. I look forward to engaging with the AZT team, the Board of Directors and our shareholders and to continue to build AZT into a world-class enzyme company”.

Dr. Marie Roskrow, ArcticZymes’ Chairman of the Board added: “We are very fortunate to have engaged Michael as our next CEO. Coulter Partners ran an excellent search process and we had a number of first-class candidates to choose from. In the end, it was Michael’s leadership experience, strategic approach and enthusiasm that made him a stand-out. We welcome Michael to AZT and wish him every success”.

Michael is an accomplished business executive with strong leadership experience, and an established reputation in the life sciences sector. He has over 20+ years of international experience in general management, business development and commercialization within the biopharma industry, including senior roles at diagnostic, med tech and CRO companies. Michael holds a BSc. (Econ) and a MSc. in International Marketing and Management from the Copenhagen Business School.

Michael will commence his position no later than 1 November 2023.

[ENDS]

Notes to editors:

About ArcticZymes Technologies ASA
ArcticZymes Technologies is a Norwegian life sciences company focused on the development, manufacturing and commercialization of novel recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing.
The company is listed on the Oslo Stock Exchange since 2005 as ArcticZymes Technologies under the [AZT] ticker. Its headquarters are based in Tromsø, Norway, at the SIVA Innovation Centre.
For more information, please visit the website: www.arcticzymes.com

About Coulter Partners
We are executive search and leadership development specialists working to build a better future. As advisors and consultants to companies at the cutting edge of Life Sciences, Health, and Technology, we are united by our mission to build teams that change the world. Operating uniquely as one global team, we have honed our expertise, platform, and data for over two decades, working across three continents, and in 40 countries. Applying what we learn through our work with boards, leadership teams, and investors in the world’s most innovative companies, we bring together and develop the right people at the right time to propel them to achieve their worthwhile goals.
For further